ABF Tourette's Disorder Post Marketing Surveillance Study
NCT01795105 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 692
Last updated 2019-04-01
Summary
This is a Post-Marketing Surveillance study of Abilify® tablets in accordance with Korean regulations on New Drug Re-examination (i.e. New Drug Re-examination Standards: KFDA Notification No. 2010-94 dated 27 December 2010).
Conditions
- Tourette's Disorder
Sponsors & Collaborators
-
Korea Otsuka Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2015-05-29
- Completion
- 2015-05-29
Countries
- South Korea
Study Locations
More Related Trials
-
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
NCT00561951 ·Status: COMPLETED ·Phase: PHASE2
-
Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)
NCT01488578 ·Status: COMPLETED
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED
-
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
NCT02485067 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
NCT01598103 ·Status: TERMINATED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder
NCT04917315 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
NCT03602508 ·Status: COMPLETED
-
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)
NCT01533597 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
NCT03492281 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
NCT03583372 ·Status: COMPLETED ·Phase: PHASE3
-
MIrabegron With oveRACtive bLadder Symptoms in mEn
NCT02361502 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
NCT00444925 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome
NCT01895153 ·Status: COMPLETED
-
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
NCT02468375 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms
NCT04420533 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
NCT00425100 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
NCT01210859 ·Status: WITHDRAWN
-
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
NCT01260311 ·Status: COMPLETED
-
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment
NCT01318837 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT00290563 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Use Investigation for Toviaz
NCT01936870 ·Status: COMPLETED
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA